标普生物科技LOF(161127)
动态评分: 6.09分
投资组合

报告日期 | 代码 | 名称 | 类型 | 金额(万元) | 占期初比 |
2023-06-30 | NTRA | Natera Inc | 卖出 | 164.37 | 0.51% |
2023-06-30 | MORF | Morphic Holding Inc | 买入 | 160.46 | 0.5% |
2023-06-30 | NVAX | 诺瓦瓦克斯医药 | 买入 | 157.77 | 0.49% |
2023-06-30 | ACAD | 阿卡迪亚 | 卖出 | 155.47 | 0.48% |
2023-06-30 | RCUS | Arcus Biosciences Inc | 买入 | 152.58 | 0.47% |
2023-06-30 | HALO | 奥洛兹美医疗 | 买入 | 153.05 | 0.47% |
2023-06-30 | BTAI | BioXcel Therapeutics Inc | 买入 | 149.49 | 0.46% |
2023-06-30 | BBIO | BridgeBio Pharma Inc | 买入 | 144.97 | 0.45% |
2023-06-30 | VRDN | Viridian Therapeutics Inc | 买入 | 144.49 | 0.45% |
2023-06-30 | TVTX | Travere Therapeutics Inc | 买入 | 142.92 | 0.44% |
2023-06-30 | PTGX | Protagonist Therapeutics Inc | 买入 | 140.3 | 0.43% |
2023-06-30 | MRNA | Moderna Inc | 买入 | 134.77 | 0.42% |
2023-06-30 | CPRX | Catalyst Pharmaceuticals Inc | 买入 | 127.35 | 0.39% |
2023-06-30 | INCY | 因塞特医疗 | 买入 | 115.62 | 0.36% |
2023-06-30 | BLUE | 蓝鸟生物 | 买入 | 116.3 | 0.36% |
2023-06-30 | FATE | Fate Therapeutics Inc | 卖出 | 112.47 | 0.35% |
2023-06-30 | PTGX | Protagonist Therapeutics Inc | 卖出 | 111.73 | 0.34% |
2023-06-30 | RCUS | Arcus Biosciences Inc | 卖出 | 103.88 | 0.32% |
2023-06-30 | ALT | Altimmune Inc | 卖出 | 99.88 | 0.31% |
2023-06-30 | GOSS | Gossamer Bio Inc | 卖出 | 98.74 | 0.3% |
公告&资料
